ALZ.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:29):

Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden...

Stats
Today's Volume	125 626
Average Volume	113 548
Market Cap	75.70M
EPS	SEK-0.0797 ( 2023-11-02 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-3.78
ATR14	SEK0.0140 (0.82%)

Volume Correlation

Long: -0.14 (neutral)

Short: 0.31 (neutral)

Signal:(50.261) Neutral

Alzinova AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alzinova AB (publ) Correlation - Currency/Commodity

0.27
( neutral )

0.56
( weak )

0.00
( neutral )

0.57
( weak )

-0.77
( moderate negative )

0.80
( moderate )

Alzinova AB (publ) Financials

Annual	2023
Revenue:	SEK270 000
Gross Profit:	SEK-16.52M (-6 119.26 %)
EPS:	SEK-0.410

Q4	2023
Revenue:	SEK270 000
Gross Profit:	SEK-4.81M (-1 782.59 %)
EPS:	SEK-0.110

Q3	2023
Revenue:	SEK3.30M
Gross Profit:	SEK6.60M (200.00 %)
EPS:	SEK-0.0797

Q2	2023
Revenue:	SEK6.02M
Gross Profit:	SEK12.04M (200.00 %)
EPS:	SEK-0.0972

Financial Reports:

No articles found.

Alzinova AB (publ)

Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden. Its lead candidate is ALZ-101, an oligomer-specific vaccine for the treatment of Alzheimer's disease; and ALZ-201, a monoclonal antibody that is used for the treatment of toxic Aß oligomers. The company was founded in 2011 and is based in Mölndal, Sweden.